Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Alpha Hydroxy Acids (AHAs) like glycolic acid gently dissolve intercellular glue, facilitating the removal of dead cells and promoting new cell growth
KLOW Peptide Composition BPC-157 : Body Protection Compound TB-500 : Thymosin Beta-4 Fragment GHK-Cu : Copper Peptide Complex KPV : Tripeptide Sequence of Lysine, Proline, and Valine Chemical Identifiers: BPC-157 Chemical Identifiers CAS Number: 137525-51-0 ChEMBL: ChEMBL4297358 ChemSpider: 8117571 DrugBank: DB11882 PubChem CID: 9941957 UNII: 8ED8NXK95P Molecular Formula: CHNO TB-500 Chemical Identifiers CAS Number: 885340-08-9 PubChem CID: 62707662 UNII: QHK6Z47GTG Molecular Formula: CHNO GHK-Cu Chemical Identifiers CAS Number: 89030-95-5 ChEMBL: CHEBL95185 ChemSpider: 335491 DrugBank: DB14683 PubChem CID: 378611 UNII: 6BJQ43T1l9 Molecular Formula: CHCuNO KPV Chemical Identifiers CAS Number: 67727-97-3 Molecular Formula: CHNO PubChem CID: 125672 ChEMBL: CHEMBL3235483 ChemSpider: 111779 DrugBank: DB05479 KLOW Research-Based Potential Benefits Each component of KLOW has been substantially researched for its healing properties, including rodent-based studies
doi: 10.3390/jcm11154611 7
doi:10.1016/j.biopsych.2013.07.036 Mizoguchi H, Yamada K, Nabeshima T (2011) Matrix metalloproteinases contribute to neuronal dysfunction in animal models of drug dependence, Alzheimers disease, and epilepsy
It acts on the GHRH-R receptor on pituitary somatotroph cells, stimulating GH synthesis and secretion through the cAMP-PKA signaling cascade
US$ 28.85
US$ 21.15
US$ 23.26
US$ 21.03
US$ 20.52
US$ 24.80
US$ 27.35
US$ 22.05
